A Brown University-led team demonstrated the utility of its "massively parallel splicing assay," or MaPSy, assay by profiling splice effects for thousands of mutations.
Presenters highlighted early work that supports the push for a national, systematic effort to elucidate progression from precancerous states to clinical malignancy.
Specialized single-cell "cores" are popping up to help scientists get the most out of new technologies.
Lucigen has signed a global agreement with Illumina to be the sole distributor of Epicentre Technologies' genomics kits, enzymes, and ancillary reagents.
Researchers reported that structural variants also tend to have larger effect sizes than single-nucleotide variants or insertions and deletions.
Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.
An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.
At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.
In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.